Article info
PDFCase Reports: Novel diagnostic procedure
Use of ctDNA in identifying an actionable BRAF mutation in stage 4 metastatic melanoma
- Correspondence to Dr Charlotte Bennett; charlotte.bennett2{at}wales.nhs.uk
Citation
Use of ctDNA in identifying an actionable BRAF mutation in stage 4 metastatic melanoma
Publication history
- Accepted June 6, 2023
- First published June 22, 2023.
Online issue publication
January 24, 2024
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© BMJ Publishing Group Limited 2023. No commercial re-use. See rights and permissions. Published by BMJ.